Show simple item record

An open-label, multicenter, efficacy and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results

dc.contributor.authorKarakaş, Zeynep
dc.date.accessioned2022-07-04T12:18:36Z
dc.date.available2022-07-04T12:18:36Z
dc.identifier.citationKarakaş Z., "An open-label, multicenter, efficacy and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results", AMERICAN JOURNAL OF HEMATOLOGY, ss.1234-12243, 2022
dc.identifier.issn0361-8609
dc.identifier.othervv_1032021
dc.identifier.otherav_16720849-7f67-4ea2-9dbf-d54fc63d4582
dc.identifier.urihttp://hdl.handle.net/20.500.12627/181728
dc.identifier.urihttps://doi.org/10.1002/ajh.26592
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp (MED)
dc.titleAn open-label, multicenter, efficacy and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results
dc.typeMakale
dc.relation.journalAMERICAN JOURNAL OF HEMATOLOGY
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.identifier.startpage1234
dc.identifier.endpage12243
dc.contributor.firstauthorID3422035


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record